Skip to content

Understanding how footwear designed to reduce toe walking affects walking patterns and comfort in children with idiopathic toe walking or toe walking associated with autism

Understanding how footwear designed to reduce toe walking affects walking patterns and comfort in children with idiopathic toe walking or toe walking associated with autism

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12626000795392
Enrollment
15
Registered
2026-07-02
Start date
2026-07-27
Completion date
2026-11-30
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

A randomised within-subject feasibility crossover study investigating the immediate effects of footwear designed to reduce toe walking on gait characteristics, heel contact, comfort and acceptability in children with idiopathic toe walking and toe walking associated with Autism Spectrum Disorder

Interventions

The intervention is a commercially available footwear (Brand name: Aerlos) design intended to reduce toe-walking gait by promoting heel contact during walking. The intervention footwear will be fitted to each participant according to manufacturer sizing recommendations and used only during the study assessment session. The intervention will be delivered by members of the research team who have expertise in paediatric gait assessment, toe walking treatment and lower limb biomechanics, including

The intervention is a commercially available footwear (Brand name: Aerlos) design intended to reduce toe-walking gait by promoting heel contact during walking. The intervention footwear will be fitted to each participant according to manufacturer sizing recommendations and used only during the study assessment session. The intervention will be delivered by members of the research team who have expertise in paediatric gait assessment, toe walking treatment and lower limb biomechanics, including paediatric podiatrists, physiotherapists and researchers experienced in gait analysis and footwear assessment. The intervention will be delivered individually during a face-to-face assessment session at Monash University in a university-based gait laboratory. Each participant will complete walking trials under three conditions: barefoot, their usual footwear, and the intervention footwear. The order of conditions will be randomised. Participants will attend a single assessment session lasting approximately 45 minutes with each condition expected to take up to 10 minutes with a wash out break of 5 minutes before each intervention being tested. During the intervention footwear condition, participants will complete repeated walking trials until three usable gait recordings are obtained. Rest breaks will be provided as required. Adherence will be monitored directly by the research team during the assessment session. Because the intervention is tested only during a supervised single-session assessment, no additional reminders or home monitoring procedures are required. Completion of all planned walking trials and successful fitting and tolerance of the intervention footwear will be recorded.

Sponsors

Monash University
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
4 Years to 8 Years
Healthy volunteers
No

Inclusion criteria

Are aged 4 to 8 years Have idiopathic toe walking or toe walking associated with Autism Spectrum Disorder Walk independently Can follow simple instructions and answer simple questions Can demonstrate heel-to-toe gait on request at least intermittently Have sufficient ankle dorsiflexion to safely participate Can walk continuously for up to 5 minutes

Exclusion criteria

Children with: Neurological or neuromuscular conditions affecting gait other than Autism Spectrum Disorder-associated toe walking Lower limb pain preventing participation Recent treatments likely to substantially alter gait (for example surgery or botulinum toxin injection) Inability to safely complete repeated walking trials

Outcome results

None listed

Source: ANZCTR · Data processed: Jul 23, 2026